Physician
Kate Fleming Berenson, M.D.
According to 2025 Medicare claims, Kate Berenson, M.D. (NPI: 1619266582) practices addiction medicine in the Dayton-Kettering-Beavercreek, OH market, with the plurality of this provider's patient population coming from Montgomery, OH. This provider's primary affiliated billing organization is CLEANSLATE MEDICAL GROUP OF OHIO LLC (NPI: 1558800193; TIN: 815341002) and primary practice location at 45439-1982. Berenson is affiliated with the Health Centers of Ohio ACO LLC (ACO ID: A5411), participating under the MSSP model.
Berenson's data goes back to 2015 and runs through 2024. For example, in 2022, this provider had 12 traditional Medicare patients, billed 30 HCPCS/CPT codes, and received $1,136 in Medicare payments. 2024 Part D data shows 927 prescription claims across 121 beneficiaries totaling $162,852 in drug costs, led by Buprenorphine-Naloxone (Buprenorphine Hcl/Naloxone Hcl). 2023 DME data shows 35 claims. Open Payments data shows 2 records totaling $35. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.
Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $33,743 to $162,852. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.